injection site rash from tirzepatide & Zepbound and Injection-Site Reactions: Causes, Treatment, and Prevention Tirzepatide & Zepbound Rash and

Smarter Metabolic Support

As patents for weight-loss drug expire from India to Canada and Brazil generic drugmakers are rushing to launch alternatives

A five-year experiment reportedly aims to expand access to blockbuster GLP1 drugs for obesity, something advocates have sought for years

Experience the power of a glp1 probiotic that Reclaim control over your eating habits with a formulation that promotes fullness and satisfaction

Here, we profiled monotherapy with semaglutide (glucagon-like-receptor-1 receptor agonist) and lanifibranor (pan-peroxisome proliferator-activated receptor agonist) in a diet-induced obese (DIO) mouse model of NASH-HCC